A broad range of Fab stabilities within a host of therapeutic IgGs.
暂无分享,去创建一个
[1] A. Plückthun,et al. Engineered turns of a recombinant antibody improve its in vivo folding. , 1995, Protein engineering.
[2] Garrett M. Morris,et al. Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.
[3] P. Carter,et al. Engineering antibodies for imaging and therapy. , 1997, Current opinion in biotechnology.
[4] A. Sarai,et al. Comparative thermodynamic analyses of the Fv, Fab* and Fab and Fab fragments of anti‐dansyl mouse monoclonal antibody , 1995 .
[5] L. Presta,et al. Antigen binding thermodynamics and antiproliferative effects of chimeric and humanized anti-p185HER2 antibody Fab fragments. , 1992, Biochemistry.
[6] H R Hoogenboom,et al. Design and application of diabodies, triabodies and tetrabodies for cancer targeting. , 2001, Journal of immunological methods.
[7] I. Pastan,et al. Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] A. Vermeer,et al. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. , 2000, Biophysical journal.
[9] N. Carter,et al. Human immunoglobulin VH and D segments on chromosomes 15q11.2 and 16p11.2. , 1994, Human molecular genetics.
[10] C. Pace,et al. How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.
[11] A. Chumanevich,et al. Antiferritin single‐chain antibody: a functional protein with incomplete folding? , 1998, FEBS letters.
[12] Jérôme Lane,et al. IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..
[13] A. Meindl,et al. The Vϰ gene repertoire in the human germ line , 1990 .
[14] A. Plückthun,et al. Stability engineering of antibody single-chain Fv fragments. , 2001, Journal of molecular biology.
[15] D. Moinier,et al. Human immunoglobulin VH and VK repertoire revealed by in situ hybridization. , 1990, Molecular immunology.
[16] Andreas Plückthun,et al. Biophysical properties of human antibody variable domains. , 2003, Journal of molecular biology.
[17] I. Tomlinson,et al. Somatic insertions and deletions shape the human antibody repertoire. , 1999, Journal of molecular biology.
[18] S. Steinbacher,et al. Sequence statistics reliably predict stabilizing mutations in a protein domain. , 1994, Journal of molecular biology.
[19] M. Lefranc,et al. Sequence and evolution of the human germline V lambda repertoire. , 1996, Journal of molecular biology.
[20] E L Sonnhammer,et al. The imprint of somatic hypermutation on the repertoire of human germline V genes. , 1996, Journal of molecular biology.
[21] M. Hurle,et al. Protein engineering techniques for antibody humanization. , 1994, Current opinion in biotechnology.
[22] D. Röthlisberger,et al. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. , 2005, Journal of molecular biology.
[23] Valérie Barbié,et al. The Human Immunoglobulin Kappa Variable (IGKV) Genes and Joining (IGKJ) Segments , 1998, Experimental and Clinical Immunogenetics.
[24] P. Brams,et al. In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. , 2000, International journal of immunopharmacology.
[25] I. Tomlinson,et al. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. , 1992, Journal of molecular biology.
[26] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[27] I. Tomlinson,et al. A directory of human germ‐line Vχ segments reveals a strong bias in their usage , 1994 .
[28] Boris Steipe,et al. Consensus-based engineering of protein stability: from intrabodies to thermostable enzymes. , 2004, Methods in enzymology.
[29] E. H. Cohen,et al. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity , 2005, Nature Biotechnology.
[30] R M Hoet,et al. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. , 1999, Journal of molecular biology.
[31] P Leder,et al. The genetics of antibody diversity. , 1982, Scientific American.
[32] H. Hoogenboom,et al. Selecting and screening recombinant antibody libraries , 2005, Nature Biotechnology.
[33] T. T. Wu,et al. AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.
[34] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..
[35] S Minoshima,et al. One-megabase sequence analysis of the human immunoglobulin lambda gene locus. , 1997, Genome research.
[36] A. Plückthun,et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. , 2000, Journal of molecular biology.
[37] J. L. López-Lacomba,et al. Differential scanning calorimetry of the irreversible thermal denaturation of thermolysin. , 1988, Biochemistry.
[38] B. E. Kimmel,et al. Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression. , 2006, Protein engineering, design & selection : PEDS.
[39] A. Plückthun,et al. The hierarchy of mutations influencing the folding of antibody domains in Escherichia coli. , 1999, Protein engineering.
[40] Andreas Plückthun,et al. Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. , 2004, Methods.
[41] Marie-Paule Lefranc,et al. The Human Immunoglobulin Heavy Variable Genes , 1999, Experimental and Clinical Immunogenetics.
[42] Lucy J. Holt,et al. Domain antibodies: proteins for therapy. , 2003, Trends in biotechnology.
[43] S. Demarest,et al. Optimization of the antibody C(H)3 domain by residue frequency analysis of IgG sequences. , 2004, Journal of molecular biology.
[44] S. Demarest,et al. An Intermediate pH Unfolding Transition Abrogates the Ability of IgE to Interact with Its High Affinity Receptor FcϵRIα* , 2006, Journal of Biological Chemistry.
[45] Z. Peng,et al. Consensus-derived structural determinants of the ankyrin repeat motif , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[46] T. Honjo,et al. Organization of the Human Immunoglobulin Heavy-Chain Locus , 1996 .